omeprazole
NDC 42507-164, omeprazole, tablet, orally disintegrating, delayed release, from HyVee Inc.
- Product NDC
- 42507-164
- Status
- Listed
- Labeler
- HyVee Inc
- Dosage form
- TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE
- Route
- ORAL
- Product type
- HUMAN OTC DRUG
- Marketing category
- NDA
- Application
- NDA209400
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/42507-164 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- OMEPRAZOLE20 mg/1
Pharmacologic classes
Cytochrome P450 2C19 Inhibitors [MoA]; Proton Pump Inhibitor [EPC]; Proton Pump Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 42507-164-42 | 42507016442 | 3 CARTON in 1 CARTON (42507-164-42) / 14 BLISTER PACK in 1 CARTON / 1 TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE in 1 BLISTER PACK |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.
Use it
Look up 42507-164 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/42507-164 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 42507-164. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.